Press Releases

The global NGS Informatics market is expected to grow at a CAGR of 15.7% during the forecast period. The term "NGS" refers to large-scale DNA sequencing methods that facilitate in genomic discovery. Factors attributing to the market growth for the NGS Informatics Market include cost-efficacy of genome and RNA sequencing, extensive deployment in research applications which include gene expression, epigenetics, metagenomics, etc., increased awareness and surging deployment of technology, continuous research and development activities, and technological development in NGS Informatics tools. The growing preference for personalized medicines and early disease detection and increased demand for NGS services and investments by key players will open many avenues for application of NGS, thereby propelling market development. Moreover, the massive increase in the amount of genomic data is driving the adoption of NGS informatics solutions for data analysis, storage, and computation. Thus, increased speed and flexibility provided by NGS software, the market for next-generation sequencing informatics is expected to grow faster during the forecast period.

Because of its ability to report on multiple biomarkers at the same time, next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling. Long turnaround times, on the other hand, may limit the clinical utility of these results. To meet the demand for rapid genomic insights, Thermo Fisher Scientific has launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx in clinical labs in August 2022.

Bowse 53 market data Tables and 35 Figures spread through 210 Pages and in-depth TOC on "NGS Informatics Market by Product (Data Analysis & Management Tools, Primary and Secondary Data Analysis Tools, and NGS Informatics Services), by Application (Drug Discovery, Genetic Screening, Biomarker Discovery, Diagnostics, Agriculture and Animal Research, and Precision Medicine), by End User (Pharmaceutical Companies, Academic and Research Centers, Hospitals and Clinics, and Others), and Region - Global Forecast to 2030

By Application, Genetic Screening segment will witness the fastest market growth during the forecast period.

Genetic Screening is expected to grow at a faster pace during the forecast period. NGS technology is extremely useful in genetic screening for identifying monogenic diseases with locus heterogeneity, like blindness, deafness, movement disorders, mitochondrial disease, hereditary cancers, and so on. It produces a huge amount of sequencing data and provides patients with a differential diagnosis.

Furthermore, NGS technologies have been extensively used in oncology screening, and the increased prevalence of cancers globally is expected to drive the market under consideration. The rising incidence of cancer and rising global awareness of preventive diagnosis and personalized medicine are the major factors driving the market over the forecast period.

Global NGS Informatics Market Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of the Global NGS Informatics Market

“Asia-Pacific is expected to witness a high CAGR in the global NGS Informatics Market during forecast period.”

Asia-Pacific is expected to have a high CAGR during the forecast period owing to an upsurge in population, rising incidences of target diseases, technological integration of NGS techniques, and several initiatives by the government to conduct research on genomic testing and understand the complex biological process and genetic mutation that are present in life-threatening diseases.

Some of the major players in the global NGS Informatics industry include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Dassault Systèmes, DNASTAR, GENEWIZ, Eagle Genomics, Abbott, and Agilent Technologies, Inc.

Scope of the Report

Global NGS Informatics Market Coverage

Product Insight and Forecast 2018-2030

• Data Analysis & Management Tools
  • Data Interpretation and Reporting Tools
  • Laboratory Information and Management Systems (LIMS)
• Primary and Secondary Data Analysis Tools
• NGS Informatics Services

Application Insight and Forecast 2018-2030

• Drug Discovery
• Genetic Screening
• Biomarker Discovery
• Diagnostics
• Agriculture and Animal Research
• Precision Medicine

End User Insight and Forecast 2018-2030

• Pharmaceutical Companies
• Academic and Research Centers
• Hospitals and Clinics
• Others

Geographical Segmentation

NGS Informatics Market by Region

North America

• By Product
• By Application
• By End User
• By Country – U.S., Canada, and Mexico

Europe

• By Product
• By Application
• By End User
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product
• By Application
• By End User
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product
• By Application
• By End User
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries